Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 102,100 KRW
Change Today +9,900 / 10.74%
Volume 1.7M
078160 On Other Exchanges
As of 2:28 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

medipost co ltd (078160) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/15 - 104,900
52 Week Low
12/30/14 - 41,650
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIPOST CO LTD (078160)

Related News

No related news articles were found.

medipost co ltd (078160) Related Businessweek News

No Related Businessweek News Found

medipost co ltd (078160) Details

Medipost Co Ltd, a stem cell biotechnology company, provides services and develops products related to human umbilical cord blood and human umbilical cord blood derived mesenchymal stem cells. It offers cord blood banking services for hematopoietic stem cell transplantation (HSCT) cases. The company also offers adult stem cell drugs, including CARTISTEM used for the treatment of knee cartilage defects; and NEUROSTEM, which is used in the treatment of patients suffering from neuro-degenerative disorders, such as Alzheimer’s disease, amyotrophic lateral sclerosis, and stroke via recovery of functionality and tissues of the central nervous system. Its adult stem cell drugs also comprise PNEUMOSTEM used for the treatment of pulmonary disorders comprising bronchopulmonary dysplasia; and PROMOSTEM that promotes early engraftment of donor hematopoietic stem cells following transplantation and improves the success rate of HSCT while minimizing the adverse immune reactions from the HSCT recipients. In addition, Medipost Co Ltd provides vitamins and nutritional supplements for the benefits of the pregnant, kids, and the elderly. The company has a strategic partnership with Dong-A Pharmaceutical Co., Ltd. for post-marketing and long-term follow up study of CARTISTEM clinical trial phases. Medipost Co Ltd was founded in 2000 and is based in Seoul, South Korea.

Founded in 2000

medipost co ltd (078160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medipost co ltd (078160) Key Developments

Medipost Co Ltd, Annual General Meeting, Mar 26, 2015

Medipost Co Ltd, Annual General Meeting, Mar 26, 2015., at 09:00 Korea Standard Time. Location: Bundang-gu, Gyeonggi-do,. Agenda: To approve the consolidated financial statements; and to consider the approval of director remuneration.

Medipost to Form Joint Venture with Jingyuan Bio-Tech, Ltd

Medipost has agreed to form a 50:50 joint venture (JV) with Jingyuan Bio-Tech, Ltd, to carry out clinical tests of Cartistem in China. Under the terms of the JV, both the partners will jointly invest USD 7 million each. Deal Value is USD 14 million. The JV, OrLife Bio, will have an exclusive license for the development and sales of Cartistem in China and be responsible for the manufacturing and registration of the product. The JV will be located in Taian, China and plans to initiate clinical trial of CARTISTEM in China in 2016 following about one year preparation period. MEDIPOST will be entitled for 50% of the JV's profit based on its equity holdings and in addition will receive license fee and royalty from the JV.

Medipost Co Ltd Presents at HSBC Asia Corporate Day 2014, Nov-17-2014

Medipost Co Ltd Presents at HSBC Asia Corporate Day 2014, Nov-17-2014 . Venue: The Mayfair Hotel, Stratton Street, London W1J 8LT, United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
078160:KS 102,100.00 KRW +9,900

078160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 078160.
View Industry Companies

Industry Analysis


Industry Average

Valuation 078160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.0x
Price/Book 6.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIPOST CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at